BioLine RX LtdNASDAQ:BLRXNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.8500
- TODAY'S CHANGE (%)-0.0216 (-2.4785%)
- Bid / Lots0.8203/ 13
- Ask / Lots0.8900/ 29
- Open / Previous Close0.8734 / 0.8716
- Day Range
- 52 Week Range
- Volume484,652
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BLRX |
|---|---|---|
| 09:32 ET | 1497 | 0.87 |
| 09:34 ET | 6136 | 0.8625 |
| 09:36 ET | 800 | 0.865 |
| 09:38 ET | 200 | 0.865 |
| 09:39 ET | 400 | 0.87 |
| 09:41 ET | 1500 | 0.87 |
| 09:43 ET | 1700 | 0.87 |
| 09:45 ET | 3199 | 0.87 |
| 09:48 ET | 10000 | 0.8725 |
| 09:50 ET | 400 | 0.8751 |
| 09:52 ET | 514 | 0.8751 |
| 09:54 ET | 400 | 0.8751 |
| 09:56 ET | 3400 | 0.8752 |
| 09:57 ET | 2400 | 0.8752 |
| 09:59 ET | 1200 | 0.8752 |
| 10:01 ET | 800 | 0.8825 |
| 10:03 ET | 1000 | 0.875 |
| 10:06 ET | 300 | 0.8751 |
| 10:08 ET | 300 | 0.8751 |
| 10:10 ET | 300 | 0.8751 |
| 10:12 ET | 430 | 0.8751 |
| 10:14 ET | 300 | 0.8751 |
| 10:15 ET | 2000 | 0.8711 |
| 10:17 ET | 8941 | 0.84 |
| 10:19 ET | 600 | 0.871 |
| 10:24 ET | 200 | 0.85 |
| 10:28 ET | 100 | 0.8708 |
| 10:39 ET | 600 | 0.87 |
| 10:42 ET | 100 | 0.8503 |
| 10:46 ET | 200 | 0.8504 |
| 11:02 ET | 100 | 0.8554 |
| 11:04 ET | 100 | 0.8505 |
| 11:08 ET | 117 | 0.8601 |
| 11:13 ET | 1000 | 0.8506 |
| 11:15 ET | 100 | 0.8505 |
| 11:18 ET | 1300 | 0.85 |
| 11:20 ET | 998 | 0.85 |
| 11:22 ET | 2243 | 0.845 |
| 11:24 ET | 1800 | 0.845 |
| 11:26 ET | 400 | 0.845 |
| 11:27 ET | 2195 | 0.867826 |
| 11:29 ET | 1400 | 0.85 |
| 11:31 ET | 300 | 0.851 |
| 11:33 ET | 400 | 0.852 |
| 11:36 ET | 400 | 0.851 |
| 11:38 ET | 300 | 0.851 |
| 11:40 ET | 950 | 0.851 |
| 11:42 ET | 300 | 0.851 |
| 11:44 ET | 300 | 0.851 |
| 11:45 ET | 400 | 0.851 |
| 11:47 ET | 300 | 0.851 |
| 11:49 ET | 400 | 0.851 |
| 11:51 ET | 400 | 0.8669 |
| 11:54 ET | 300 | 0.85 |
| 11:56 ET | 300 | 0.85 |
| 11:58 ET | 300 | 0.85 |
| 12:00 ET | 300 | 0.85 |
| 12:02 ET | 300 | 0.85 |
| 12:03 ET | 300 | 0.85 |
| 12:05 ET | 1000 | 0.851 |
| 12:07 ET | 300 | 0.851 |
| 12:09 ET | 1123 | 0.851 |
| 12:12 ET | 700 | 0.86 |
| 12:14 ET | 615 | 0.8654 |
| 12:16 ET | 300 | 0.851 |
| 12:20 ET | 1600 | 0.85 |
| 12:21 ET | 100 | 0.85 |
| 12:23 ET | 300 | 0.85 |
| 12:25 ET | 300 | 0.85 |
| 12:27 ET | 300 | 0.85 |
| 12:30 ET | 200 | 0.85 |
| 12:32 ET | 600 | 0.85 |
| 12:34 ET | 300 | 0.85 |
| 12:36 ET | 300 | 0.85 |
| 12:38 ET | 300 | 0.85 |
| 12:39 ET | 400 | 0.85 |
| 12:41 ET | 200 | 0.8653 |
| 12:54 ET | 100 | 0.8653 |
| 12:56 ET | 700 | 0.8652 |
| 12:57 ET | 1659 | 0.8652 |
| 12:59 ET | 3799 | 0.8407 |
| 01:01 ET | 3600 | 0.8653 |
| 01:03 ET | 100 | 0.8407 |
| 01:06 ET | 400 | 0.84 |
| 01:08 ET | 10100 | 0.8653 |
| 01:10 ET | 300 | 0.84 |
| 01:12 ET | 200 | 0.84 |
| 01:14 ET | 800 | 0.84 |
| 01:15 ET | 500 | 0.8401 |
| 01:17 ET | 10200 | 0.86 |
| 01:19 ET | 20300 | 0.84 |
| 01:21 ET | 100 | 0.84 |
| 01:24 ET | 21300 | 0.84 |
| 01:26 ET | 700 | 0.8255 |
| 01:28 ET | 499 | 0.8189 |
| 01:30 ET | 800 | 0.86 |
| 01:32 ET | 3200 | 0.8179 |
| 01:33 ET | 1100 | 0.82 |
| 01:35 ET | 700 | 0.82 |
| 01:37 ET | 2429 | 0.818 |
| 01:39 ET | 500 | 0.818 |
| 01:42 ET | 400 | 0.818 |
| 01:44 ET | 1400 | 0.82 |
| 01:46 ET | 800 | 0.82 |
| 01:48 ET | 400 | 0.82 |
| 01:50 ET | 4000 | 0.818 |
| 01:51 ET | 3500 | 0.818 |
| 01:53 ET | 1000 | 0.818 |
| 01:55 ET | 900 | 0.8179 |
| 01:57 ET | 21802 | 0.86 |
| 02:00 ET | 400 | 0.8501 |
| 02:02 ET | 500 | 0.8501 |
| 02:04 ET | 500 | 0.8501 |
| 02:06 ET | 500 | 0.8501 |
| 02:08 ET | 10830 | 0.8501 |
| 02:09 ET | 2800 | 0.8511 |
| 02:11 ET | 6052 | 0.8519 |
| 02:13 ET | 15628 | 0.8601 |
| 02:15 ET | 1400 | 0.8601 |
| 02:18 ET | 8001 | 0.8601 |
| 02:20 ET | 2800 | 0.8601 |
| 02:22 ET | 15454 | 0.8879 |
| 02:24 ET | 15300 | 0.8801 |
| 02:26 ET | 11500 | 0.8801 |
| 02:27 ET | 38608 | 0.8801 |
| 02:29 ET | 32538 | 0.855 |
| 02:31 ET | 4400 | 0.85 |
| 02:33 ET | 2800 | 0.8703 |
| 02:36 ET | 1000 | 0.852 |
| 02:38 ET | 1300 | 0.862 |
| 02:40 ET | 1100 | 0.861 |
| 02:42 ET | 2200 | 0.85 |
| 02:44 ET | 1800 | 0.85 |
| 02:45 ET | 10652 | 0.852 |
| 02:47 ET | 1309 | 0.8328 |
| 02:49 ET | 3563 | 0.835 |
| 02:51 ET | 4620 | 0.835 |
| 02:54 ET | 2000 | 0.835 |
| 02:56 ET | 900 | 0.835 |
| 02:58 ET | 300 | 0.83 |
| 03:00 ET | 2400 | 0.8192 |
| 03:02 ET | 7300 | 0.84 |
| 03:03 ET | 1900 | 0.8179 |
| 03:05 ET | 13566 | 0.8179 |
| 03:07 ET | 1517 | 0.813 |
| 03:09 ET | 100 | 0.8131 |
| 03:12 ET | 2000 | 0.813 |
| 03:14 ET | 7598 | 0.815 |
| 03:16 ET | 1100 | 0.813 |
| 03:18 ET | 600 | 0.813 |
| 03:20 ET | 200 | 0.815 |
| 03:21 ET | 400 | 0.815 |
| 03:23 ET | 800 | 0.815 |
| 03:25 ET | 300 | 0.815 |
| 03:27 ET | 800 | 0.815 |
| 03:30 ET | 1000 | 0.815 |
| 03:32 ET | 1500 | 0.82 |
| 03:34 ET | 1800 | 0.82 |
| 03:36 ET | 1000 | 0.82 |
| 03:38 ET | 600 | 0.8155 |
| 03:39 ET | 5600 | 0.816 |
| 03:41 ET | 123 | 0.8256 |
| 03:43 ET | 2119 | 0.839 |
| 03:45 ET | 10310 | 0.84 |
| 03:48 ET | 200 | 0.84 |
| 03:50 ET | 1000 | 0.84 |
| 03:52 ET | 4023 | 0.85 |
| 03:56 ET | 500 | 0.848 |
| 03:59 ET | 2500 | 0.8441 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
BioLine RX Ltd | 62.4M | -1.1x | --- |
LAVA Therapeutics NV | 55.5M | -1.9x | --- |
Marker Therapeutics Inc | 47.2M | -3.9x | --- |
MediciNova Inc | 63.8M | -7.6x | --- |
Kronos Bio Inc | 80.5M | -0.7x | --- |
Kezar Life Sciences Inc | 47.9M | -0.5x | --- |
Company Information
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Contact Information
- Headquarters
- Modi'in Technology Park 2 HaMa'ayan StreetMODIIN, Israel 7177871
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Aharon Schwartz
- Chief Executive Officer
- Philip Serlin
- Chief Financial Officer
- Mali Zeevi
- Vice President - Development
- Ella Sorani
- Vice President-Clinical & Medical Affairs
- Abi Vainstein-Haras
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $62.4M |
|---|---|
Revenue (TTM) | $11.7M |
Shares Outstanding | 79.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.44 |
EPS | $-0.76 |
Book Value | $0.18 |
P/E Ratio | -1.1x |
Price/Sales (TTM) | 5.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -391.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
